MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4)

International Immunology

Volumn 16, Issue 7, 2004, Pages 895-904

  Stohl, William ^c   Xu, Dong ^c   Kim, Kyoung Soo ^c   David, Chella S ^a   Allison, James P ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CD4+ cells; CD8+ cells; Ig secreting cells; IgG; IgM

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL COUNT; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 3242739436     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh091     Document Type: Article

References (55)

1. Leung, H. T., Bradshaw, J., Cleaveland, J. S. and Linsley, P. S. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270:25107.
2. Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L. and Mittler, R. S. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4:535.
3. Egen, J. G. and Allison, J. P. 2002. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16:23.
4. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., Thompson, C. B. and June, C. H. 1993. Characterization of CTLA-4 structure and expression human T cells. J. Immunol. 151:3489.
5. Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ladbetter, J. A., Anasetti, C. and Damle, N. K. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
6. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
7. Alegre, M.-L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L. and Thompson, C. B. 1996. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J. Immunol. 157:4762.
8. + T lymphocytes. J. Immunol. 169:6231.
9. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
10. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A. Jr, Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulated human T cell proliferation. Science 262:909.
11. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. and Hodes, R. J. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
12. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
13. Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L. and Thompson, C. B. 2000. Structural analysis of CTLA-4 function in vitro. J. Immunol. 164:5319.
14. Carreno, B. M., Bennett, F., Chau, T. A., Ling, V., Luxenberg, D., Jussif, J., Baroja, M. L. and Madrenas, J. 2000. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its levels of cell surface expression. J. Immunol. 165:1352.
15. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C. and Puccetti, P. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097.
16. Martin, M., Schneider, H., Azouz, A. and Rudd, C. E. 2001. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J. Exp. Med. 194:1675.
17. Krummel, M. F. and Allison, J. P. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
18. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
19. Krummel, M. F. and Allison, J. P. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
20. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
21. McCoy, K., Camberis, M. and Le Gros, G. 1997. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 186:183.
22. + T cells. J. Immunol. 164:664.
23. Leach, D. R., Krummel, M. F. and Allison, J. P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
24. Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D. and Bluestone, J. A. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
25. Perrin, P. J., Maldonado, J. H., Davis, T. A., June, C. H. and Racke, M. K. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333.
26. Lühder, F., Höglund, P., Allison, J. P., Benoist, C. and Mathis, D. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
27. Hurwitz, A. A., Sullivan, T. J., Sobel, R. A. and Allison, J. P. 2002. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl Acad. Sci. USA 99:3013.
28. Perez, V. L., van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B. and Abbas, A. K. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
29. Eager, T. N., Karandikar, N. J., Bluestone, J. A. and Miller, S. D. 2002. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur. J. Immunol. 32:972.
30. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
31. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
32. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
33. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
34. + T cells. Immunity 7:885.
35. Chambers, C. A., Cado, D., Truong, T. and Allison, J. P. 1997. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl Acad. Sci. USA 94:9296.
36. Waterhouse, P., Bachmann, M. F., Penninger, J. M., Ohashi, P. S. and Mak, T. W. 1997. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27:1887.
37. + T cells. Eur. J. Immunol. 28:3137.
38. + TCR-transgenic T cells: lack of correlation with Scr homology domain 2-containing protein tyrosine phosphatase. J. Immunol. 166:3900.
39. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. and Sharpe, A. H. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14:145.
40. Gozalo-Sanmillan, S., McNally, J. M., Lin, M. Y., Chambers, C. A. and Berg, L. J. 2001. Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice. J. Immunol. 166:727.
41. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C. and Mathis, D. 1991. Mice lacking MHC class II molecules, Cell 66:1051.
42. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
43. + cells and human MHC class II. Int. Immunol. 13:1291.
44. Nabozny, G. H., Baisch, J. M., Cheng, S., Cosgrove, D., Griffiths, M. M., Luthra, H. S. and David, C. S. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27.
45. Stohl, W., Posnett, D. N. and Chiorazzi, N. 1987. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J. Immunol. 138:1667.
46. Gronowicz, E., Coutinho, A. and Melchers, F. 1976. A plaque assay for all cells secreting Ig of a given type or class. Eur. J. Immunol. 6:588.
47. Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J. et al. 2003. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 100:8372.
48. Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G. et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506.
49. Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B. and Sharpe, A. H. 1997. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158:5091.
50. Mandelbrot, D. A., McAdam, A. J. and Sharpe, A. H. 1999. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189:435.
51. + T-helper and T-killer cell. Nature 393:474.
52. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P. and Heath, W. R. 1998, Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
53. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R. and Melief, C. J. M. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
54. + T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197:997.
55. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. and Abrignani, S. 2003. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197:1051.